Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
aducanumab
advances in neurology
adverse drug reaction
algorithm
Alzheimer's disease
Alzheimer's disease, early onset
Alzheimer's disease, pathogenesis
Alzheimer's disease, treatment of
amyloid
amyloid angiopathy, cerebral
amyloid angiopathy, cerebral, inflammatory type
amyloid beta protein
amyloid beta protein antibodies
amyloid beta-related angiitis
amyloid deposition
amyloid plaques
amyloid-related imaging abnormalities
aneurysm
aneurysm, intracranial
angiitis
angiitis, granulomatous of CNS
angiitis, isolated of CNS
anti-amyloid therapy
anticoagulant, reversal of
anticoagulant, treatment
apolipoprotein E
apoliprotein E, plasma level
B 12 deficiency
Behcet's syndrome
biologic markers
blood pressure
brain biopsy
carbon monoxide poisoning
CAT scan
CAT scan, emission
CAT scan, emission, abnormal
central nervous system, infection of
central pontine myelinolysis
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebral venous thrombosis
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident, complications with
cerebrovascular disease
chemotherapy, CNS treatment and complications with
coma
complications
confusion
contraindications
controversies in neurology
cortical blindness
cost
coumarin
dementia
dementia, rapidly progressive
dementia, reversible
dementia, treatment of
demyelinating disease
disease modifying agents
dizziness
donanemab
efficacy
emergency room
emergency room, treatment of stroke
encephalitis, human immunodeficiency virus type 1
encephalitis, viral
enzyme inhibition
gadolinium
gantenerumab
Glasgow coma score
gliomatosis cerebri
granulomatous disease
headache
hearing loss
hemosiderosis of CNS, superficial
hemosiderosis, subarachnoid
human immunodeficiency virus type 1
hypertension
hypertensive encephalopathy
iatrogenic neurologic disorders
immunomodulation
intracerebral hemorrhage
intracerebral hemorrhage, causes of
intracerebral hemorrhage, clot evacuation
intracerebral hemorrhage, pathophysiology
intracerebral hemorrhage, small
intracranial pressure, increased
intracranial pressure, increased, treatment of
lecanemab
leukoencephalopathy
leukoencephalopathy, differential diagnosis
limbic encephalitis
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
meningeal biopsy
meningeal enhancement
mental status, abnormal
microhemorrhage, intracerebral
migraine
mild cognitive impairment
misdiagnosis
mitochondrial disease
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, mass effect on
multiple sclerosis
myoclonus
negative
neoplasm, primary of CNS
neurologic examination, focal
neuropathology
phenylketonuria
Pittsburgh Compound B
platelet inhibiting drugs
pleocytosis of cerebrospinal fluid
posterior leukoencephalopathy syndrome
prevention of neurologic disorders
prognosis
progressive multifocal leucoencephalopathy
radiation therapy, CNS treatment and complications with
recombinant activated factor VII
remternetug
reversible neurologic disorder
review article
risk factors
safety
sarcoidosis
sarcoidosis, CNS
seizure
shared decision making
symmetric brain lesions
temporal lobe
tissue plasminogen activator, intravenous
TRAILBLAZER-ALZ trial
transient neurologic deficit
treatment of neurologic disorder
vasculitides
vasculopathy
Whipple's disease
white matter disease
Showing articles 0 to 50 of 11262 Next >>

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

Amyloid-Related Imaging Abnormalities:An Update
AJR 220:562-575, Roytman,M.,et al, 2023

Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023

Severe Amyloid-Related Imaging Abnormalities After Anti-B-Amyloid Monoclonal Antibody Treatment
Neurol 101:1079-1080, Bonami,S.,et al, 2023

Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023

Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021

Rapid Progression of Reversible Cognitive Impairment in an 80-year-old Man
Neurol 91:1109-1113, Bouthour, W.,et al, 2018

Antiamyloid Therapy for Alzheimers Disease - Are We on the Right Road?
NEJM 370:377-378, Karran, E. & Hardy, J., 2014

Amyloid-Beta Related Angiitis of the Central Nervous System: Case Report and Topic Review
Front Neurol 5:1-4, Nouh, A.,et al, 2014

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

Phase 2 Safety Trial Targeting Amyloid � Production With a ?-Secretase Inhibitor in Alzheimer Disease
Arch Neurol 65:1031-1038, Fleisher,A.S.,et al., 2008

Disease-Modifying Therapies for Alzheimers: New Drugs on the Horizon
Practical Neurology 7:16-23, Christensen,D.B., 2008

Intracerebral Hemorrhage
The Neurologist 11:311-324, Badjatia,N. &Rosand,J., 2005

Acute Leukoencephalopathies:Differential Diagnosis and Investigation
The Neurologist 4:148-166, Weinshenker,B.G.,et al, 1998

Dextromethorphan-Associated Neurotoxicity with Cerebellar Edema Syndrome in Young Children:Neuroimaging Features
AJNR 46:390-394, Sharma,S.,et al, 2025

A 56-Year-Old Woman with New-Onset Hoarsement and Dysphagia
Neurol 104:e213363, McAree,M. & Frontera, J.A., 2025

Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025

Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025

A 67 YEar-Old Woman with Progressive Headache, Visual Hallucinations, and Seizures
Neurol 104:e213496, Gheihman,G.,et al, 2025

Diagnosis and Management of ANCA-Associated Vasculitis
Lancet 403:683-698, Kronbichler, A., et al, 2024

Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024

Clinicopathologic Conference, Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis
NEJM 390:843-851, Case 7-2024, 2024

Lecanemab for Alzheimer Disease, Is It Worth It?
Neurol 102:e209265, Nelson,S.E. & Lopez,O.L., 2024

Posttransplant Anti-GABAA Receptor Antibody-Associated Autoimmune Encephalitis
Neurol 102:e209245, Togni,C.L.,et al, 2024

Clinicopathologic Conference, Myasthenia Gravis
NEJM 391:1441-1450, Case 32-2024, 2024

Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024

Diffusely Enhancing Lesions on MRI in DPPX Antibody-Associated Encephalitis
JAMA Neurol 8:418-419, Liu,M.,et al, 2024

Clinicopathological Conference, Glutamic Acid Decarborylase 65 Autoantibody-Associated Stiff-Person Syndrome
NEJM 390:1712-1719, Case 14-2024, 2024

Expanding Clinical Spectrum an Anti-GQ1b Antibody Syndrome, A Review
JAMA Neurol 81:762-770, Lee,S-U.,et al, 2024

Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Ann Neurol 96:21-33, Gilligan,M.,et al, 2024

Diagnosing Cerebral Amyloid Angiopathy-Related Inflammation
Neurol 103:e209548, Charidimou,A., 2024

Clinical Presentation, Management, and Outcome in Neurolymphomatosis, A Systematic Review
Neurol 103:e209698, Kaulen.L.D.,et al, 2024

Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Melanoma
Neurol 101:e2472-e2482, Pepys,J.,et al, 2023

NSAIDS, Hormonal Contraception, and Venous Thromboembolism, A Harmful Drug Interaction That Deserves More Attention
BMJ 382:p1990, Schmidt,M., 2023

Surgical Decompression for Malignant Cerebral Edema After Ischemic Stroke:Cochrane Review
Stroke 54:e500-5502, Dower,A.,et al, 2023

Polymyalgia Rheumatica
Lancet 402:1459-1472, Espigol-Frigole,G.,et al, 2023

Clinicopathologic Conference, Systemic Immunoglobulin Light-Chain (AL) Amyloidosis
NEJM 389:166-175, Case 21-2023, 2023

Progressive Hemiparesis and White Matter Abnormalities in an HIV-Negative Patient
Neurol 100:1156-1163, Jabbari,E.,et al, 2023

Long-Term Outcomes of Bariatric Surgery in Idiopathic Intracranial Hypertension Patients
Neurologist 28:87-93, Hermes,S.M.,et al, 2023

Antithrombotic Therapy in Patients with Cerebral Microbleeds or Cortical Siderosis, Is This Contraindicated?
Neurol 100:551-552, Schneck,M.J., &Biller,J., 2023

Iatrogenic Cerebral Amyloid Angiopaty Post Neurosurgery:Frequency, Clinical Profile, Radiological Features, and Outcome
Stroke 54:1214-1223, 1224, Kaushik,K.,et al, 2023

Clinical,Neuroimaging,and Genetic Markers in Cerebral Amyloid Angiopatny-Related Inflammation:A Systematic Review and Meta-Analusis
Stroke 54:178-188, Theodorou,A.,et al, 2023

A 67-Year-Old Woman with Progressive Tingling Sensations and Imlalance
Neurol 100:151-157, Horta,L.F.B.,et al, 2023

Cortical Superficial Siderosis and Transient Focal Neurological Episode Preceding Lobar Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 54:e48-e51, Therdorou,A.,et al, 2023

Association of Amount of Weight Lost After Bariatric Surgery with Intracranial Pressure in Women with Idiopathic Intracranial Hypertension
Neurol 99:e1090-e1099, Mollan, S.P.,et al, 2022

In Patients with Melanoma Brain Metastases, is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic
Neurologist 27:290-297, Gritsch, D.,et al, 2022

Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022

A 55-Year-Old Woman with Recurrent Episodes of Aphasia and Vision Changes
Neurol 98:330-335, Jeanneret, V.,et al, 2022



Showing articles 0 to 50 of 11262 Next >>